Similarities between Oxidopamine and Parkinson's disease
Oxidopamine and Parkinson's disease have 6 things in common (in Unionpedia): Dopamine, Dopaminergic, MPTP, Parkinsonism, Rotenone, Substantia nigra.
Dopamine
Dopamine (DA, a contraction of 3,4-dihydroxyphenethylamine) is an organic chemical of the catecholamine and phenethylamine families that plays several important roles in the brain and body.
Dopamine and Oxidopamine · Dopamine and Parkinson's disease ·
Dopaminergic
Dopaminergic means "related to dopamine" (literally, "working on dopamine"), dopamine being a common neurotransmitter.
Dopaminergic and Oxidopamine · Dopaminergic and Parkinson's disease ·
MPTP
MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a prodrug to the neurotoxin MPP+, which causes permanent symptoms of Parkinson's disease by destroying dopaminergic neurons in the substantia nigra of the brain.
MPTP and Oxidopamine · MPTP and Parkinson's disease ·
Parkinsonism
Parkinsonism is a clinical syndrome characterized by tremor, bradykinesia, rigidity, and postural instability.
Oxidopamine and Parkinsonism · Parkinson's disease and Parkinsonism ·
Rotenone
Rotenone is an odorless, colorless, crystalline isoflavone used as a broad-spectrum insecticide, piscicide, and pesticide.
Oxidopamine and Rotenone · Parkinson's disease and Rotenone ·
Substantia nigra
The substantia nigra (SN) is a basal ganglia structure located in the midbrain that plays an important role in reward and movement.
Oxidopamine and Substantia nigra · Parkinson's disease and Substantia nigra ·
The list above answers the following questions
- What Oxidopamine and Parkinson's disease have in common
- What are the similarities between Oxidopamine and Parkinson's disease
Oxidopamine and Parkinson's disease Comparison
Oxidopamine has 18 relations, while Parkinson's disease has 323. As they have in common 6, the Jaccard index is 1.76% = 6 / (18 + 323).
References
This article shows the relationship between Oxidopamine and Parkinson's disease. To access each article from which the information was extracted, please visit: